|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date29 May 1981 |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date15 Apr 1960 |
|
MechanismNMDA receptor antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with AH Robins LLC
0 Patents (Medical) associated with AH Robins LLC
100 Deals associated with AH Robins LLC
100 Translational Medicine associated with AH Robins LLC